These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 1639340)
1. Cholesterol metabolism in human gallbladder mucosa: relationship to cholesterol gallstone disease and effects of chenodeoxycholic acid and ursodeoxycholic acid treatment. Sahlin S; Ahlberg J; Reihnér E; Ståhlberg D; Einarsson K Hepatology; 1992 Aug; 16(2):320-6. PubMed ID: 1639340 [TBL] [Abstract][Full Text] [Related]
2. Cholesterol metabolism in liver and gallbladder mucosa of patients with cholesterolosis. Sahlin S; Ståhlberg D; Einarsson K Hepatology; 1995 May; 21(5):1269-75. PubMed ID: 7737633 [TBL] [Abstract][Full Text] [Related]
3. Hepatic cholesterol and bile acid metabolism in subjects with gallstones: comparative effects of short erm feeding of chenodeoxycholic and ursodeoxycholic acid. Carulli N; Ponz De Leon M; Zironi F; Pinetti A; Smerieri A; Iori R; Loria P J Lipid Res; 1980 Jan; 21(1):35-43. PubMed ID: 7354253 [TBL] [Abstract][Full Text] [Related]
4. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment. Ahlberg J; Angelin B; Einarsson K J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966 [TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic acid treatment in cholesterol gallstone disease: effects on hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity, biliary lipid composition, and plasma lipid levels. Angelin B; Ewerth S; Einarsson K J Lipid Res; 1983 Apr; 24(4):461-8. PubMed ID: 6854153 [TBL] [Abstract][Full Text] [Related]
6. Distribution of cholesterol between vesicles and micelles in human gallbladder bile: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid. Sahlin S; Thyberg P; Ahlberg J; Angelin B; Einarsson K Hepatology; 1991 Jan; 13(1):104-10. PubMed ID: 1988332 [TBL] [Abstract][Full Text] [Related]
8. Effect of chenodeoxycholic acid and ursodeoxycholic acid administration on acyl-CoA: cholesterol acyltransferase activity in human liver. Abate N; Carubbi F; Bozzoli M; Bertolotti M; Farah I; Rosi A; Carulli N Ital J Gastroenterol; 1994; 26(6):287-93. PubMed ID: 7949265 [TBL] [Abstract][Full Text] [Related]
9. Hepatic cholesterol metabolism in estrogen-treated men. Angelin B; Olivecrona H; Reihnér E; Rudling M; Ståhlberg D; Eriksson M; Ewerth S; Henriksson P; Einarsson K Gastroenterology; 1992 Nov; 103(5):1657-63. PubMed ID: 1426886 [TBL] [Abstract][Full Text] [Related]
10. Hepatic HMGCoA reductase in human cholelithiasis: effects of chenodeoxycholic and ursodeoxycholic acids. Maton PN; Ellis HJ; Higgins MJ; Dowling RH Eur J Clin Invest; 1980 Aug; 10(4):325-32. PubMed ID: 6775960 [TBL] [Abstract][Full Text] [Related]
11. Effects of chenodeoxycholic and ursodeoxycholic acids on lipid metabolism and gallstone formation in the prairie dog. Cohen BI; Singhal AK; Stenger RJ; May-Donath P; Finver-Sadowsky J; McSherry CK; Mosbach EH Hepatology; 1984; 4(2):300-7. PubMed ID: 6706304 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of cholesterol monohydrate crystals in gallbladder and hepatic bile in man: influence of bile acid treatment. Sahlin S; Ahlberg J; Angelin B; Ewerth S; Nilsell K; Reihnér E; Einarsson K Eur J Clin Invest; 1988 Aug; 18(4):386-90. PubMed ID: 3139424 [TBL] [Abstract][Full Text] [Related]
13. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. Reihnér E; Rudling M; Ståhlberg D; Berglund L; Ewerth S; Björkhem I; Einarsson K; Angelin B N Engl J Med; 1990 Jul; 323(4):224-8. PubMed ID: 2114543 [TBL] [Abstract][Full Text] [Related]
14. Effect of litholytic bile acids on cholesterol absorption in gallstone patients. LaRusso NF; Thistle JL Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406 [TBL] [Abstract][Full Text] [Related]
15. Effect of ursodeoxycholic acid on hepatic cholesterol metabolism. Einarsson K Scand J Gastroenterol Suppl; 1994; 204():19-23. PubMed ID: 7824873 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid on bile acid kinetics and biliary lipid secretion in humans. Evidence for different modes of action on bile acid synthesis. Nilsell K; Angelin B; Leijd B; Einarsson K Gastroenterology; 1983 Dec; 85(6):1248-56. PubMed ID: 6628924 [TBL] [Abstract][Full Text] [Related]
17. Cholesterol, bile acid, and lipoprotein metabolism in two strains of hamster, one resistant, the other sensitive (LPN) to sucrose-induced cholelithiasis. Férézou J; Combettes-Souverain M; Souidi M; Smith JL; Boehler N; Milliat F; Eckhardt E; Blanchard G; Riottot M; Sérougne C; Lutton C J Lipid Res; 2000 Dec; 41(12):2042-54. PubMed ID: 11108738 [TBL] [Abstract][Full Text] [Related]
18. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin. Sahlin S Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223 [TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of chenodeoxycholic and ursodeoxycholic acids in obese patients. Effects on biliary lipid metabolism during weight maintenance and weight reduction. Mazzella G; Bazzoli F; Festi D; Ronchi M; Aldini R; Roda A; Grigolo B; Simoni P; Villanova N; Roda E Gastroenterology; 1991 Aug; 101(2):490-6. PubMed ID: 2065925 [TBL] [Abstract][Full Text] [Related]
20. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study. Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]